相似文献
1
Atherosclerosis: Association between the gut microbiome and atherosclerosis.
Nat Rev Cardiol. 2017 Dec;14(12):699-700. doi: 10.1038/nrcardio.2017.169. Epub 2017 Nov 3.
2
Metagenomics, culturomics, and the human gut microbiota.
Expert Rev Anti Infect Ther. 2018 May;16(5):373-375. doi: 10.1080/14787210.2018.1467268. Epub 2018 Apr 23.
3
Role of gut microbiota in atherosclerosis.
Nat Rev Cardiol. 2017 Feb;14(2):79-87. doi: 10.1038/nrcardio.2016.183. Epub 2016 Dec 1.
4
The gut microbiome in atherosclerotic cardiovascular disease.
Nat Commun. 2017 Oct 10;8(1):845. doi: 10.1038/s41467-017-00900-1.
5
[Impact of newly developed metagenomic tools on our knowledge of the gut microbiota and its role in human health: diagnostic and therapeutic issues].
Med Sci (Paris). 2016 Nov;32(11):944-951. doi: 10.1051/medsci/20163211009. Epub 2016 Dec 23.
6
Intestinal Microbiota Metabolism and Atherosclerosis.
Chin Med J (Engl). 2015 Oct 20;128(20):2805-11. doi: 10.4103/0366-6999.167362.
7
Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach.
Drug Dev Res. 2019 Feb;80(1):86-97. doi: 10.1002/ddr.21466. Epub 2018 Oct 28.
8
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
Genome Biol. 2017 Jul 27;18(1):142. doi: 10.1186/s13059-017-1271-6.
9
Human Gut Microbiome: Function Matters.
Trends Microbiol. 2018 Jul;26(7):563-574. doi: 10.1016/j.tim.2017.11.002. Epub 2017 Nov 22.
10
Social behavior and the microbiome.
Elife. 2015 Mar 31;4:e07322. doi: 10.7554/eLife.07322.
引用本文的文献
1
Cascade-activatable NIR-II fluorescent carbonic anhydrase inhibitors for imaging-guided cuproptosis/chemodynamic combination therapy of colorectal cancer.
Chem Sci. 2025 Aug 13. doi: 10.1039/d5sc04668h.
2
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach.
Eur J Med Res. 2025 Jul 30;30(1):690. doi: 10.1186/s40001-025-02937-1.
3
Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE mice.
J Nanobiotechnology. 2025 Jun 3;23(1):412. doi: 10.1186/s12951-025-03444-5.
4
Molecular Mechanisms and Emerging Precision Therapeutics in the Gut Microbiota-Cardiovascular Axis.
Cureus. 2025 Apr 26;17(4):e83022. doi: 10.7759/cureus.83022. eCollection 2025 Apr.
5
Ferroptosis, pathogenesis and therapy in AS co-depression disease.
Front Pharmacol. 2025 Feb 24;16:1516601. doi: 10.3389/fphar.2025.1516601. eCollection 2025.
6
Fecal bacteria transplantation replicates aerobic exercise to reshape the gut microbiota in mice to inhibit high-fat diet-induced atherosclerosis.
PLoS One. 2025 Feb 4;20(2):e0314698. doi: 10.1371/journal.pone.0314698. eCollection 2025.
7
Effects of Artemisia asiatica ex on Akkermansia muciniphila dominance for modulation of Alzheimer's disease in mice.
PLoS One. 2024 Oct 28;19(10):e0312670. doi: 10.1371/journal.pone.0312670. eCollection 2024.
8
Impact of the gut microbiome on atherosclerosis.
mLife. 2024 Apr 1;3(2):167-175. doi: 10.1002/mlf2.12110. eCollection 2024 Jun.
9
From heart to gut: Exploring the gut microbiome in congenital heart disease.
Imeta. 2023 Oct 30;2(4):e144. doi: 10.1002/imt2.144. eCollection 2023 Nov.
10
Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases.
Imeta. 2023 Jun 19;2(3):e124. doi: 10.1002/imt2.124. eCollection 2023 Aug.
本文引用的文献
1
The gut microbiome in atherosclerotic cardiovascular disease.
Nat Commun. 2017 Oct 10;8(1):845. doi: 10.1038/s41467-017-00900-1.
2
Gut Microbiota and Atherosclerosis.
Curr Atheroscler Rep. 2017 Aug 25;19(10):39. doi: 10.1007/s11883-017-0675-9.
3
Role of gut microbiota in atherosclerosis.
Nat Rev Cardiol. 2017 Feb;14(2):79-87. doi: 10.1038/nrcardio.2016.183. Epub 2016 Dec 1.
4
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
Cell. 2016 Mar 24;165(1):111-124. doi: 10.1016/j.cell.2016.02.011. Epub 2016 Mar 10.
5
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.
Cell. 2015 Dec 17;163(7):1585-95. doi: 10.1016/j.cell.2015.11.055.
6
Personalized Nutrition by Prediction of Glycemic Responses.
Cell. 2015 Nov 19;163(5):1079-1094. doi: 10.1016/j.cell.2015.11.001.
7
Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.
Atherosclerosis. 2015 Aug;241(2):387-99. doi: 10.1016/j.atherosclerosis.2015.05.035. Epub 2015 Jun 3.
8
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
N Engl J Med. 2013 Apr 25;368(17):1575-84. doi: 10.1056/NEJMoa1109400.
9
The impact of the gut microbiota on human health: an integrative view.
Cell. 2012 Mar 16;148(6):1258-70. doi: 10.1016/j.cell.2012.01.035.
Zotero 插件